A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Conditions
Squamous Cell Carcinoma of Head and Neck · Sinus Cancer · Nasal Cavity Cancer · Oral Cavity Cancer · Oropharynx Cancer · Hypopharynx Cancer · Larynx Cancer · Oral Squamous Cell Carcinoma · Oropharynx Squamous Cell Carcinoma · Hypopharynx Squamous Cell Carcinoma · Larynx Squamous Cell Carcinoma · HPV Positive Oropharyngeal Squamous Cell Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack, New York, United States
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York, New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
Study leads
Winston Wong, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center